Legacy App Modernization in Dublin for Insurance, Banking and Pharma

ZTABS modernizes legacy applications for Dublin enterprises in insurance, banking, pharmaceutical manufacturing and technology. Dublin hosts European headquarters for major insurers, banks and technology companies operating legacy platforms accumulated over decades. Insurance carriers run legacy policy administration systems processing billions in premiums. Banks operate COBOL mainframe cores. Pharma manufacturers run validated MES and ERP systems. ZTABS is remote-first by design from our Houston, Texas office.

Dublin's legacy modernization demand spans insurance platform modernization for CBI-regulated carriers, banking core system migration, pharma manufacturing system upgrades with GMP Annex 11 compliance, and technology platform decomposition for EMEA headquarters.

Legacy app modernization in Dublin at a glance

Need	What we build	Key requirement
Insurance	Platform modernization	CBI, Solvency II, DORA
Banking	Core system migration	CBI, PSD2, SEPA Instant
Pharma	MES and ERP upgrades	GMP Annex 11, HPRA
Technology	Platform decomposition	GDPR, DPC one-stop-shop
Financial services	System consolidation	Consumer Protection Code

Insurance platform modernization

Dublin insurers operate legacy policy administration, claims and actuarial systems reflecting decades of market evolution. Multiple predecessor brands with separate legacy systems require consolidation.

Policy administration. Life, health and P&C insurance policy lifecycle modernized. Actuarial calculations for pricing, reserving and reporting preserved and verified. CBI reporting dependencies addressed at each migration phase.

Claims processing. Claims workflow modernized for digital submission, automated assessment rules and faster settlement. Fraud detection integration enabled. Multiple legacy claims systems consolidated.

Regulatory reporting. CBI Solvency II reporting, National Claims Information Database submissions, actuarial returns and corporate governance requirements addressed in modernized systems. DORA resilience testing addressed.

Consumer Protection Code. Effective 24 March 2026 with actual scope for regulated financial services. Product governance, disclosure and conduct requirements addressed in modernized customer-facing systems.

Banking core system modernization

Dublin banks operate COBOL mainframe core banking and payment processing systems. PSD2 open banking, SEPA Instant and digital banking requirements driving modernization.

Core banking migration. Account management, transaction processing, general ledger and customer information migrating from COBOL mainframes. CBI supervisory expectations and DORA requirements addressed at each migration phase.

SEPA Instant and PSD2. Legacy batch-oriented payment processing modernized for real-time SEPA Instant capability and PSD2 compliant APIs.

Ulster Bank withdrawal context. Ulster Bank withdrawal is historical context, not current banking partner. Migrating business from legacy Ulster Bank systems to successor providers. Account number changes, direct debit migrations and standing order transfers managed.

Pharma manufacturing modernization

Dublin pharma manufacturers operate validated MES and ERP systems requiring modernization while maintaining regulatory compliance.

MES modernization. Manufacturing execution systems modernized for real-time production monitoring, batch record management and quality analytics. EU GMP Annex 11 current requirements, not consultation draft requirements. GAMP 5 risk-based approach.

ERP upgrades. SAP and Oracle ERP systems with pharma-specific customisation migrated to current versions. Validation documentation addressed at each migration phase.

HPRA. HPRA (Health Products Regulatory Authority) regulates pharmaceutical manufacturing, marketing authorisations, GMP inspections and pharmacovigilance in Ireland. Actual manufacturer holds the MIA and qualified person responsibilities. Software agency does not hold MIA. Not every system change requires HPRA approval; actual manufacturer, QP and system validation responsibilities determine scope.

ICH CTD. Common Technical Document format for regulatory submissions. Clinical trial SUSAR reporting and EudraVigilance pharmacovigilance versus CTIS actual routes where applicable. Batch record retention derives from actual predicate GMP and product rules, not a generic Annex 11 retention period.

Irish regulation

GDPR and DPC. DPC one-stop-shop only for actual cross-border processing with main establishment determination authority, not every Irish company. Actual main establishment determination criteria. Multiple actual processing bases available.

Irish electronic marketing. Consent or sale own similar opt-out at collection and each message. Initial message within 12 months. Distinct from other EU member state implementations.

Consumer Protection Code. Effective 24 March 2026. Actual scope for regulated financial services. Product governance and conduct requirements.

CBI and DORA. CBI actual regulated entity, product and DORA scope. ICT risk management, incident reporting, third-party risk management and resilience testing. CBI outsourcing notification for actual entity and material function triggers.

Revenue R&D. 35% credit per eBrief 085/26 of 23 April 2026 with actual specified return date and eligible accounting period conditions per current Revenue primary guidance. Qualifying technology advancement and uncertainty criteria apply. Routine modernization does not automatically qualify as R&D expenditure.

EU GMP Annex 11. Current requirements versus consultation draft distinction. Computer system validation requirements for pharma manufacturing.

Strangler fig for Dublin systems

Seam selection. Insurance seams: policy administration, claims, actuarial, regulatory reporting. Banking seams: accounts, payments, lending, reporting. Pharma seams: production, quality, distribution, regulatory. Each function extracted independently with regulatory compliance maintained.

Single authoritative write. One system authoritative for each transaction type and period during coexistence. Insurance dual-write dangerous for actuarial reporting. Banking dual-write dangerous for CBI regulatory reporting. CDC with versioning and conflict detection.

Reconciliation. Idempotency keys enforced by receiving side. Finite retries with DLQ. Unknown outcomes require reconciliation before replay, especially for insurance premium settlements, SEPA payments and pharma batch records.

Data migration methodology

Insurance data. Policy records, claims history, actuarial data, reinsurance treaties and regulatory reporting data migrated with actuarial verification. Historical claims data preserved for reserving and reporting.

Banking data. Account records, transaction history and regulatory data migrated with reconciliation against agreed record totals, tolerances and exception register with owner acceptance. CBI regulatory reporting data addressed at each migration phase.

Pharma data. Batch records, quality data, validation documentation, regulatory submission data and stability data migrated with GMP Annex 11 compliance. Electronic signatures and audit trails preserved.

Data type mapping. Types, nulls, time zones, currency, rounding, identifiers, encoding, history and crosswalks reconciled. Irish-specific: PPS number handling per data protection requirements, insurance policy identifiers, CBI regulatory reporting fields, pharma batch record identifiers. EUR currency precision.

Cutover rehearsal. Observable acceptance with measurable RTO, RPO and latency targets. Insurance cutover timed for renewal cycles. Banking cutover timed for settlement cycles. Pharma cutover planned for production schedule gaps.

Inventory and discovery

Dublin enterprise modernization begins with complete inventory: applications, users, scheduled jobs, database procedures, reports, file and EDI dependencies, vendor contracts, supported versus end-of-life versions.

Business rules discovered with users through representative transaction analysis. Insurance rules validated against CBI requirements and actuarial standards. Banking rules validated against CBI requirements. Pharma rules validated against GMP Annex 11 and HPRA requirements.

Modernization approach selection

Dublin enterprises need clear criteria for choosing between approaches.

Targeted remediation. Adding specific capabilities. Example: adding API layer to legacy policy system for digital portal while keeping legacy for core processing.

Re-platforming. Moving to modern infrastructure while preserving logic. Example: migrating legacy billing to cloud while preserving actuarial algorithms.

Re-architecture. Decomposing monolith into services. Example: extracting claims, policy administration and actuarial as independent services.

Full rebuild. Ground-up development for systems where legacy code is unmaintainable.

Regression and testing

Representative business-critical paths: insurance policy lifecycle with premium and claims, banking transaction lifecycle, pharma production batch record. Meaningful integration, performance and manual UAT with domain expert approval.

Cost and timeline

Legacy system modernization follows the published cost guide.

Tier	Range	Timeline	Example
UI Modernization	$40K to $100K	8 to 16 weeks	New frontend, API wrapper, improved UX
Re-Platforming	$100K to $250K	16 to 32 weeks	Modern stack, containerization, cloud, data migration
Re-Architecture	$250K to $400K	8 to 14 months	Decompose monolith, event-driven, modern data layer
Full Rebuild	$400K to $500K+	12 to 18+ months	Ground-up rebuild, agreed availability target, rehearsed staged cutover

Vendor comparison

Ranges are 2026 US-buyer guide-based estimates for re-platforming a 10 to 15 year old business-critical system using a strangler fig approach, modern stack, API wrappers, phased data migration and regression harness.

Vendor type	Typical cost	Timeline
Freelance or dev collective	$40K to $130K	5 to 12 months
Offshore systems integrator	$60K to $200K	8 to 14 months
ZTABS	$100K to $280K	6 to 12 months
Big 4 consultancy	$300K to $1M+	10 to 18 months
SaaS replacement vendor	$50K to $200K implementation	4 to 9 months

Parallel-running infrastructure, senior knowledge-transfer time and where applicable compliance revalidation can add a combined scope-dependent $100K to $500K+ planning allowance. The guide's examples are SOX, HIPAA and FDA; actual applicable regime depends on the engagement.

Proposal evaluation criteria

Evaluate any vendor proposal against these six criteria regardless of price tier.

Criterion	What to verify
Strategy, deliverables and acceptance	Defined modernization phases with measurable acceptance criteria at each stage
Data source-of-truth and reconciliation	Which system is authoritative per object and period, agreed reconciliation tolerances and exception register
Rehearsal, cutover and rollback	Rehearsed cutover with RTO and RPO targets, documented rollback feasibility after schema and data changes
Security, privacy, compliance and approval scope	Applicable regulations identified with actual approval authority and scope
Full recurring costs	Licensing, parallel-run infrastructure, support, monitoring and decommission costs beyond initial build
Human roles and responsibilities	Provider and customer trainer-validator-support split, agreed working languages, translated materials review and on-site responsibilities where needed

How delivery works

ZTABS is remote-first by design from our Houston, Texas office. Overlap with Dublin business hours for coordination and review.

When ZTABS is not the right fit

• The system still works and nobody is asking for changes. Wait for a real forcing function.
• Insurance platform vendor selection. Insurance administration platform licence selection, actuarial product configuration and vendor-led deployment are the licensed vendor's and customer's scope. This engagement modernizes the surrounding integration, data migration and regulatory reporting connections.
• On-site programme office and multi-vendor coordination. This engagement delivers application modernization. Separately contracted programme governance, on-site management and advisory retainers have different scope and responsibilities.
• On-site embedded team. ZTABS is remote-first by design. On-site staffing, training and support retainers for this engagement are separately agreed.
• CBI or DPC regulatory advisory. This engagement builds platforms, not regulatory advice. Regulatory advisory is separately engaged.

White-label AI products

ZTABS builds custom white-label AI products for clients to brand and resell. Dublin technology companies can commission white-label AI platforms for distribution under their own brand.

Logs and retention

Logs minimise and redact secrets and regulated payloads with actual retention and legal holds. Revenue 6 year baseline retention for financial records. Insurance records retained per CBI requirements and actuarial needs. Pharma batch records retained per actual predicate GMP Chapter 4 product rules and manufacturer or QP ownership, not a generic Annex 11 retention period. PPS numbers minimised and pseudonymised where full identifier unnecessary.

Integration and dependency management

Insurance integrations. CBI regulatory reporting, reinsurance treaty connections, Motor Insurers Bureau, Health Insurance Authority, National Claims Information Database submissions.

Banking integrations. CBI regulatory reporting, SEPA payment networks, card scheme connections, PSD2 open banking APIs, credit bureau connections.

Pharma integrations. HPRA regulatory reporting, EudraVigilance pharmacovigilance, supply chain and distribution connections, quality management system connections.

Authentication versus authorisation. Authentication identity distinct from policy-level, account-level and role-level authorisation. Modernization addresses both with appropriate granularity.

Data type mapping for Dublin industries

Dublin industry data has unique types requiring careful migration planning. Insurance: policy identifiers across multiple predecessor brands, CBI regulatory reporting fields, actuarial valuation dates, claims reference numbers. Banking: IBAN formats with Irish bank codes, CBI reporting fields, PPS number handling per data protection requirements. Pharma: batch record identifiers, GMP validation record identifiers, product codes per regulatory registrations.

Assessment methodology

Application archaeology for Dublin systems covers legacy insurance policy system analysis for business rule extraction, COBOL programme analysis for banking transaction rules, MES and ERP analysis for pharma manufacturing workflows and regulatory reporting analysis for CBI and HPRA compliance verification.

Technology platform modernization

Dublin hosts European headquarters for major technology companies operating monolithic platforms requiring modernization.

EMEA platform decomposition. Monolithic enterprise platforms serving European markets decomposed into modern services. Multi-language, multi-currency and multi-regulatory support enabled. GDPR DPC one-stop-shop considerations for main establishment.

SaaS platform modernization. Dublin-based SaaS companies modernizing legacy architectures for scale, performance and multi-tenant isolation. API-first approach enabling third-party integrations.

Cutover rehearsal detail

Observable acceptance with measurable RTO, RPO and latency targets. Insurance cutover timed for renewal cycles. Banking cutover timed for settlement cycles. Pharma cutover planned for production schedule gaps.

Rollback feasibility assessed after schema, data and contract changes. Insurance premium settlements, banking payments and pharma batch records may not be automatically reversible. Compensations can require actuarial, regulatory or quality review.

Risks and mitigations

CBI regulatory continuity. Regulatory reporting addressed at each migration phase. CBI notification for actual entity and material function outsourcing triggers where required.

Pharma validation continuity. GMP Annex 11 validation documentation addressed at each migration phase. GAMP 5 voluntary risk-based approach for computerised system changes. ICH CTD and EudraVigilance submission capability addressed at each phase with actual manufacturer and QP responsibilities.

Multi-market insurance complexity. Each European market migrated independently with market-specific regulatory validation. Cross-border reinsurance and portfolio transfer arrangements addressed at each migration phase. Motor Insurers Bureau and Health Insurance Authority data flows preserved.

Logs and fiscal retention detail

Revenue requires 6 year retention for financial records as baseline. Insurance actuarial records retained beyond statutory minimum where ongoing reporting obligations exist. Pharma batch records retained per product lifecycle and regulatory inspection requirements. CBI audit trail requirements for regulated entities.

Handover

Modernization handover includes runbooks, data lineage, licensing, support contacts and accountable owners. Insurance handover includes CBI compliance documentation and DORA resilience evidence. Pharma handover includes validation documentation, GMP Annex 11 compliance records and HPRA reporting specifications.